Literature DB >> 25894383

p55γ functional mimetic peptide N24 blocks vascular proliferative disorders.

Jiaojiao Guo1, Ning Xie1, Geng Li1, Yan Zhang1, Fengxiang Lv1, Sile Guo1, Yuanqing Feng1, Chun-Mei Cao2, Rui-Ping Xiao3,4,5,6.   

Abstract

UNLABELLED: Proliferation and migration disorders of vascular smooth muscle cells (VSMCs) contribute to the pathogenesis of proliferative cardiovascular diseases. Although, over the past two decades, a large panel of drugs has been developed for targeting VSMC proliferation, cardiovascular disease remains the leading cause of death worldwide. Thus, there is a compelling need to identify novel signaling pathways and molecules controlling VSMC proliferation and migration, to provide not only mechanistic insights but also safe and effective therapies for the treatment of cardiovascular diseases. Our recent studies have demonstrated that p55γ, a regulatory subunit of phosphoinositide 3-kinase, functions as an endogenous brake on VSMC proliferation. Here, we demonstrate that the small peptide N24, the first 24 amino acids of the NH2 terminus of p55γ, is a functional mimetic which negatively regulates VSMC proliferation and migration. Specifically, luminal delivery of adenovirus expressing N24 or local administration of Tat transactivator protein (TAT)-tagged N24 by pluronic gel alleviates neointimal formation following balloon injury in rat carotid arteries. Enforced expression of N24 suppresses the proliferation and migration of VSMCs induced by serum- or platelet-derived growth factor-BB. Mechanistically, N24 induces cell cycle arrest via activating the p53-p21 signal pathway, without triggering cell death. N24 interacts with and stabilizes p53 by blocking its ubiquitin-dependent degradation, subsequently promotes p21 transcription, and arrests cell cycle progression. Indeed, knockdown of p21 or p53 abrogates the N24-mediated cell growth arrest. Thus, N24 is a p55γ mimetic inhibiting VSMC proliferation as well as migration, thereby conferring important therapeutic implications for anti-proliferative treatment. KEY MESSAGE: • N24 attenuates balloon injury-induced neointimal formation. • Overexpression of N24 inhibits cultured VSMC proliferation and migration. • Overexpression of N24 arrests the cell cycle at S phase. • N24 interacts with and stabilizes p53 resulting in growth suppression.

Entities:  

Keywords:  Migration; Neointimal formation; Proliferation; Restenosis; Vascular smooth muscle cells; p55γ

Mesh:

Substances:

Year:  2015        PMID: 25894383     DOI: 10.1007/s00109-015-1287-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  35 in total

1.  Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor.

Authors:  B Witzenbichler; Y Kureishi; Z Luo; A Le Roux; D Branellec; K Walsh
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  The N-terminal 34 residues of the 55 kDa regulatory subunits of phosphoinositide 3-kinase interact with tubulin.

Authors:  K Inukai; M Funaki; M Nawano; H Katagiri; T Ogihara; M Anai; Y Onishi; H Sakoda; H Ono; Y Fukushima; M Kikuchi; Y Oka; T Asano
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

Review 3.  Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

Authors:  Victor J Dzau; Ruediger C Braun-Dullaeus; Daniel G Sedding
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 4.  Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.

Authors:  J J Escobar-Chávez; M López-Cervantes; A Naïk; Y N Kalia; D Quintanar-Guerrero; A Ganem-Quintanar
Journal:  J Pharm Pharm Sci       Date:  2006       Impact factor: 2.327

Review 5.  Cell cycle progression: new therapeutic target for vascular proliferative disease.

Authors:  R C Braun-Dullaeus; M J Mann; V J Dzau
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

Review 6.  Drug eluting stents: an updated meta-analysis of randomised controlled trials.

Authors:  C Roiron; P Sanchez; A Bouzamondo; P Lechat; G Montalescot
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

7.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

8.  The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase.

Authors:  S Pons; T Asano; E Glasheen; M Miralpeix; Y Zhang; T L Fisher; M G Myers; X J Sun; M F White
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

9.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

10.  Production of transforming growth factor beta 1 during repair of arterial injury.

Authors:  M W Majesky; V Lindner; D R Twardzik; S M Schwartz; M A Reidy
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more
  3 in total

1.  A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics.

Authors:  Natalia Petrasheskaya; Hyun-Jin Tae; Ismayil Ahmet; Mark I Talan; Edward G Lakatta; Li Lin
Journal:  J Vis Exp       Date:  2016-09-19       Impact factor: 1.355

2.  SRSF1 promotes vascular smooth muscle cell proliferation through a Δ133p53/EGR1/KLF5 pathway.

Authors:  Ning Xie; Min Chen; Rilei Dai; Yan Zhang; Hanqing Zhao; Zhiming Song; Lufeng Zhang; Zhenyan Li; Yuanqing Feng; Hua Gao; Li Wang; Ting Zhang; Rui-Ping Xiao; Jianxin Wu; Chun-Mei Cao
Journal:  Nat Commun       Date:  2017-08-11       Impact factor: 14.919

3.  Hydrogen-free hydrogenation of nitrobenzene via direct coupling with cyclohexanol dehydrogenation over ordered mesoporous MgO/SBA-15 supported Cu nanoparticles.

Authors:  Ravi Kumar Marella; Venkata Rao Madduluri; Sivarama Krishna Lakkaboyana; Marlia M Hanafiah; Sarala Yaaratha
Journal:  RSC Adv       Date:  2020-10-22       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.